Page 15 - Respiratory Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Respiratory sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Respiratory Sciences Today - Breaking & Trending Today

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections. ....

European Union , European Centre For Disease Prevention , Disease Prevention , European Economic Area , Respiratory Syncytial Virus , Monoclonal Antibody ,

Philips Reaches Agreement With FDA on Ventilator Recall -- 2nd Update

By Elena Vardon Royal Philips reached an agreement with the U.S. Food and Drug Administration on the terms of a settlement linked to recall of its. ....

Noord Holland , United States , Marc Hesselink , Elena Vardon , Philips Respironics , Roy Jakobs , Department Of Justice , Drug Administration , Executive Roy Jakobs , Respiratory Care , North American , Article Normal , Respiratory Allergy Treatments , Medical Equipment Supplies , Healthcare Life Sciences , Specialized Drugs Medications , Regulation Government Policy , Financial Performance , Sales Figures , New Products Services , Product Consumer Safety , Product Service Approvals , Corporate Industrial News , Products Services , Product Recalls , Content Types ,

Inhibrx, Sanofi ratify $2.2B deal for AATD therapy

Inhibrx Inc. and Sanofi SA have agreed to a deal worth up to $2.2 billion, whereby the latter’s Aventis Inc. subsidiary will acquire INBRX-101, an optimized, recombinant alpha-1 antitrypsin (AAT) augmentation therapy undergoing a registrational trial for AAT deficiency (AATD), an inherited genetic disorder caused by single nucleotide variants in the SERPINA1 gene. ....

Aventis Inc , Inhibrx Inc , Inhibrx Inc , Sanofi Sa , Inbrx 101 , Aventis Inc , Alpha 1 Antitrypsin Deficiency , Deals Andm Amp A , Aat Deficiency , Korro Bio Inc , Beam Therapeutics Inc , Mereo Biopharma Group Plc ,

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus. ....

Los Angeles , United States , Rio De Janeiro , Estado Do Rio , Jae Jung , Mary Cambou , Tamiris Azamor , Sophia Paiola , Karin Nielsen , Tara Kerin , Jessica Cranston , Thalia Mok , Infectologia Evandro Chagas , Viviana Fajardo , Weiqiang Chen , Rashmi Rao , Ucla Wm Keck Foundation , Simons Foundation Autism Research Initiative , Research Award Program , Nature Communications , University Of California , Los Angeles Health Sciences , David Geffen School Of Medicine , National Institutes Of Health , Angeles Health , David Geffen School ,

Increase in hard-to-kick coughs due to year-end rise in acute respiratory infections

SINGAPORE: More people suffered from hard-to-kick coughs in Singapore in the last few months of 2023, as respiratory viruses hit high gear. ....

Leong Pei Yi , Sewa Duu Wen , Vikram Mengi , Dana Elliott Srither , Ministry Of Health , Straits Times , Critical Care Medicine , Singapore General Hospital ,